Dimas / Cork / Park / Milan / City / Foster City / /
Company
Gilead Sciences Inc. / PARI Pharma GmbH / 2011 Arresto BioSciences / ACE / Medicines Patent Pool Gilead / Human Resources / Company Overview Gilead Sciences Inc. / Pfizer Inc. / HIV / Generic Manufacturers / CGI Pharmaceuticals / Pharmasset / AMD / Myogen / Rapidscan Pharma Solutions Inc. / Eyetech Inc. / B. Partners / WHO Group / Access Countries Emerging Markets Partnerships / Altera / Triangle Pharmaceuticals / Robin L. Washington / Bristol-Myers Squibb Company / PhD / Calistoga Pharmaceuticals / NeXstar / F. Hoffmann-La Roche Ltd. / Astellas Pharma US Inc. / CV Therapeutics / A2A / GlaxoSmithKline PLC / YM BioSciences / /
Continent
Europe / North America / South America / /
Country
Canada / United Kingdom / New Zealand / Belgium / United States / Ireland / Czech Republic / /
Currency
USD / / /
Event
FDA Phase / Company Expansion / M&A / Earnings Announcement / /
Facility
International Headquarters / /
IndustryTerm
imaging / manufacturing / HIV therapies / treatment of life-threatening diseases / therapies for HIV / pharmaceutical / healthcare / research-based biopharmaceutical / biopharmaceutical / treatment of HIV / /
World Health Organization / European Union / Harvard / /
Person
John C. Martin / Katie L. Watson / Norbert W. Bischofberger / Kevin Young / John F. Milligan / Gregg H. Alton / / /
Position
Chairman and Chief Executive Officer / Vice President / chief executive officer / Vice President and Chief Financial Officer / Executive Vice President / Research and Development / and Chief / President and Chief Operating Officer / Officer / health care CEO / Executive Vice President / /
Gilead Sciences Advancing Therapeutics. Improving Lives.